Novo Nordisk partners with OpenAI in weight loss drug race
- Posted on April 14, 2026
- By The Hill
- 10 Views
Novo Nordisk partners with OpenAI in weight loss drug race
Novo Nordisk, the maker of popular weight-loss drugs Ozempic and Wegovy, is partnering with OpenAI to deploy the technology across its operations as it looks to keep pace with rapid expan…
